CX3CR1 and prostate cancer: In vivo animal models showed that the overexpression of CX3CR1 induced the spinal metastasis of prostate cancer via the FKN/steroid receptor coactivator (Src)/focal adhesion kinase (FAK) signaling pathway [337].